Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TYO/4888 stock hub

TYO/4888 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4888is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.6B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4888

In the news

Latest news · TYO/4888

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.7P50 15.8P75 21.7

Trailing P/En/a

P25 11.7P50 15.2P75 22.3

ROE-9.8

P25 -1.6P50 7.1P75 11.9

ROIC-3.9

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4888 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

JPY

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	43
Employees Change	-1%
Employees Change Percent	-2.27
Enterprise value	JPY 16.7B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Biotechnology
Isin	JP3399680002
Last refreshed	2026-05-10
Market cap	JPY 18.6B
Price	JPY 530
Price currency	JPY
Rev Per Employee	22,511,627.91x
Sector	Healthcare
Sic	2836
Symbol	tyo/4888
Website	https://www.stella-pharma.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.5%
EV Earnings	-59.72x
EV/Sales	17.21x
P/B ratio	6.89x
P/S ratio	19.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-23.55%
EBITDA Margin	-20.12%
Gross margin	87.81%
Gross Profit	JPY 850M
Gross Profit Growth	209.09%
Gross Profit Growth Q	-17.81%
Gross Profit Growth3 Y	71.33%
Net Income	JPY -279M
Net Income Growth Years	2%
Pretax Margin	-28.62%
Profit Margin	-28.82%
Profit Per Employee	JPY -6.5M
ROA	-2.89
Roa5y	-11.16
ROCE	-5.03
ROE	-9.84
Roe5y	-50.22
ROIC	-3.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	60.66%
Cagr3y	14.08%
Cagr5y	-2.48%
EPS Growth Years	2
Revenue Growth	199.69x
Revenue Growth Q	-28.24x
Revenue Growth Years	3x
Revenue Growth3 Y	71.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 0.2
Assets	JPY 4.8B
Cash	JPY 2.7B
Current Assets	JPY 4.6B
Current Liabilities	JPY 247M
Debt	JPY 786M
Debt Equity	JPY 0.29
Equity	JPY 2.7B
Interest Coverage	-38
Liabilities	JPY 2.1B
Long Term Assets	JPY 139M
Long Term Liabilities	JPY 1.8B
Net Cash	JPY 1.9B
Net Cash By Market Cap	JPY 10.26
Net Cash Growth	-27.81%
Net Debt Equity	JPY -0.71
Tangible Book Value	JPY 2.7B
Tangible Book Value Per Share	JPY 77.92
WACC	5.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.77
Inventory Turnover	0.09
Net Working Capital	JPY 1.9B
Quick ratio	13.21
Working Capital	JPY 4.4B
Working Capital Turnover	JPY 0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	60.61%
200-day SMA	394
3Y total return	48.46%
50-day SMA	588.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-11.81%
All Time High	1,070
All Time High Change	-50.47%
All Time High Date	2022-01-04
All Time Low	200
All Time Low Change	165%
All Time Low Date	2025-12-22
ATR	59.41
Beta	0.27
Beta1y	0.14
Beta2y	0.76
Ch YTD	161.1
High	543
High52	995
High52 Date	2026-03-25
High52ch	-46.73%
Low	518
Low52	200
Low52 Date	2025-12-22
Low52ch	165%
Ma50ch	-9.91%
Price vs 200-day SMA	34.52%
RSI	41.6
RSI Monthly	55.15
RSI Weekly	54.01
Sharpe ratio	0.97x
Sortino ratio	1.8
Total Return	-4.11%
Tr YTD	161.1
Tr1m	-17.57%
Tr1w	0.95%
Tr3m	68.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY -228M
Operating margin	-23.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,843,041%
Shares Insiders	4.11%
Shares Institutions	-2.47%
Shares Out	35,034,041
Shares Qo Q	-0.01%
Shares Yo Y	4.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,573,335x
Bv Per Share	79.21
Ch1m	-17.57
Ch1w	0.95
Ch1y	60.61
Ch3m	68.79
Ch3y	48.46
Ch5y	-11.81
Ch6m	76.08
Change	-0.38%
Change From Open	1.53
Close	532
Days Gap	-1.88
Depreciation Amortization	33,250,000
Dollar Volume	183,168,000
Earnings Date	2026-05-15
EBIT	JPY -228M
EBITDA	JPY -194.8M
EPS	JPY -8.2
F Score	3
Fiscal Year End	March
Founded	2,007
Income Tax	JPY 2M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Ma150	391.3
Ma150ch	35.44%
Ma20	622.8
Ma20ch	-14.9%
Next Earnings Date	2026-05-15
Open	522
Position In Range	48
Ppne	50,000,000
Price Date	2026-05-08
Ptbv Ratio	7
Relative Volume	0.22x
Revenue	968,000,000x
Tax By Revenue	0.21x
Tr6m	76.08%
Volume	345,600
Z Score	4.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TYO/4888 pay a dividend?

Capital-return profile for this ticker.

Performance

TYO/4888 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4888?

Insider, institutional, and short-interest positioning.

Institutional ownership

-2.5%

Share of float held by funds and institutions

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.1%

Negative means the company is buying back shares.

Technical

TYO/4888 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

+34.5%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4888

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4888 stock rating?

tyo/4888 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4888 analysis?

The full report lives at /stocks/tyo/4888/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4888?

The latest report frames tyo/4888 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4888 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.